Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Capmatinib is an oral, selective, ATP-competitive c-Met kinase inhibitor that in···【more】
Release date：2024-08-09Recommended：367
Pemigatinib is a targeted drug that is mainly used to treat cholangiocarcinoma.H···【more】
Release date：2024-08-09Recommended：280
Capmatinib is a lung cancer drug that targets specific genetic mutations, especi···【more】
Release date：2024-08-09Recommended：342
Pemigatinibis a targeted drug for the treatment of cholangiocarcinoma and belong···【more】
Release date：2024-08-09Recommended：282
Capmatinib is a targeted therapy for the treatment of non-small cell lung cancer···【more】
Release date：2024-08-09Recommended：336
Exkivity reduces the growth of non-small cell lung cancer by binding to and inhi···【more】
Release date：2024-08-09Recommended：316
Exkivity works by binding to and blocking EGFR exon 20 insertion mutations, whic···【more】
Release date：2024-08-09Recommended：331
Exkivity was granted accelerated FDA approval in 2021 based on results from the ···【more】
Release date：2024-08-09Recommended：362
Exkivity capsules can be used by adults with non-small cell lung cancer that has···【more】
Release date：2024-08-09Recommended：253
Exkivity (mobocertinib) is a tyrosine kinase inhibitor (TKI) used to treat non-s···【more】
Release date：2024-08-09Recommended：288
Exkivity (mobocertinib) is a tyrosine kinase inhibitor (TKI) used to treat non-s···【more】
Release date：2024-08-09Recommended：277
Capmatinib targets the activity of MET receptors and blocks the tumor cell growt···【more】
Release date：2024-08-08Recommended：351
